{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:17:26Z","timestamp":1750173446092},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,4]]},"DOI":"10.7759\/cureus.42968","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T22:27:31Z","timestamp":1691188051000},"source":"Crossref","is-referenced-by-count":2,"title":["A Novel Therapy for a Rare Condition: Continuous Anakinra Infusion for a Patient With Macrophage Activation Syndrome"],"prefix":"10.7759","author":[{"given":"Mitch","family":"Gullickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta P","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020, 2:e358-67. 10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11135","article-title":"Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome","volume":"2","author":"Monteagudo LA","year":"2020","unstructured":"Monteagudo LA, Boothby A, Gertner E. Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatol. 2020, 2:276-82. 10.1002\/acr2.11135","journal-title":"ACR Open Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli R","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still's disease. J Autoimmun. 2018, 93:24-36. 10.1016\/j.jaut.2018.07.018","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter SJ","year":"2019","unstructured":"Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology (Oxford). 2019, 58:5-17. 10.1093\/rheumatology\/key006","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12002","article-title":"Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra","volume":"42","author":"Loh NK","year":"2012","unstructured":"Loh NK, Lucas M, Fernandez S, Prentice D. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra. Intern Med J. 2012, 42:1358-62. 10.1111\/imj.12002","journal-title":"Intern Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4095-1","article-title":"Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature","volume":"37","author":"S\u00f6nmez HE","year":"2018","unstructured":"S\u00f6nmez HE, Demir S, Bilginer Y, \u00d6zen S. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol. 2018, 37:3329-35. 10.1007\/s10067-018-4095-1","journal-title":"Clin Rheumatol"},{"key":"ref9","unstructured":"Hemophagocytic Lymphohistiocytosis (HLH) in Adults. (2023). Accessed. February 7, 2023: https:\/\/www.dynamed.com\/condition\/hemophagocytic-lymphohistiocytosis-hlh-in-adults."},{"key":"ref10","article-title":"Treatment and prognosis of hemophagocytic lymphohistiocytosis","author":"McClain K","year":"2022","unstructured":"McClain K. Treatment and prognosis of hemophagocytic lymphohistiocytosis. UpToDate. Post TW (ed): UpToDate, UpToDate; 2022."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112810","article-title":"Adult-onset Still's disease-a complex disease, a challenging treatment","volume":"23","author":"Macovei LA","year":"2022","unstructured":"Macovei LA, Burlui A, Bratoiu I, et al.. Adult-onset Still's disease-a complex disease, a challenging treatment. Int J Mol Sci. 2022, 23:12810. 10.3390\/ijms232112810","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174767-a-novel-therapy-for-a-rare-condition-continuous-anakinra-infusion-for-a-patient-with-macrophage-activation-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:08Z","timestamp":1707508928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174767-a-novel-therapy-for-a-rare-condition-continuous-anakinra-infusion-for-a-patient-with-macrophage-activation-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.42968","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,4]]}}}